 |
|
The G93C Mutation in Superoxide Dismutase 1
Clinicopathologic Phenotype and Prognosis
Luc Régal, MD;
Ludo Vanopdenbosch, MD;
Petra Tilkin, RN;
Ludo Van Den Bosch, PhD;
Vincent Thijs, MD, PhD;
Rafael Sciot, MD, PhD;
Wim Robberecht, MD, PhD
Arch Neurol. 2006;63:262-267.
Background Twenty percent of familial amyotrophic lateral sclerosis (ALS) is caused by mutations in the superoxide dismutase 1 gene (SOD1). Few data exist on their clinicopathologic phenotypes.
Objectives To determine the clinical and pathologic phenotype associated with the G93C mutation in SOD1 and to compare survival in familial ALS related to this mutation with survival in other ALS subgroups.
Design Retrospective study.
Setting Tertiary referral center for neuromuscular disorders.
Patients Twenty patients with the G93C mutation for whom clinical data were available and 1 patient with pathologic data.
Main Outcome Measures Characteristics and survival compared with other ALS subgroups, adjusting for known prognostic factors.
Results The G93C mutation was associated with a purely lower motor neuron phenotype without bulbar involvement. Presence of the mutation independently predicted longer survival compared with other ALS subgroups. Pathologic examination showed degeneration of the anterior horn, spinocerebellar tracts, and posterior funiculi, with minimal involvement of corticospinal tracts and no degeneration of brainstem motor nuclei. Survival motor neuron gene copy number had no significant influence on age at onset or survival in patients with the G93C mutation.
Conclusions These findings add to the knowledge of SOD1-related familial ALS and demonstrate further clinicopathologic variability between different SOD1 mutations. Finally, they demonstrate the independent prognostic value of the G93C mutation.
Author Affiliations: Departments of Neurology and Experimental Neurology (Drs Régal, Vanopdenbosch, Van Den Bosch, Thijs, and Robberecht and Ms Tilkin) and Pathology (Dr Sciot), University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium. Dr Vanopdenbosch is now with the Department of Neurology, AZ Sint-Jan, Brugge, Belgium.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Sporadic ALS with early-onset respiratory failure is not associated with IGHMBP2 gene mutations
Kuhnlein et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:737-738.
FULL TEXT
The history of progressive muscular atrophy: Syndrome or disease?
Visser et al.
Neurology 2008;70:723-727.
ABSTRACT
| FULL TEXT
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish
Lemmens et al.
Hum Mol Genet 2007;16:2359-2365.
ABSTRACT
| FULL TEXT
|
